RE:RE:legacy shareholder whiningI would not say that management has done a poor job of running the company. They actually have made a lot of really good decisions in the last couple of years that should have translated into better stock performance. Where they are weak is in selling their story to the market. They just had the best thing that ever happened to the company in its long history - the ability to be a phase III NASH player - and the stock is still lower than it was prior to the announcement. It is incredible that management actually pulled that off but what is the point if when they do amazing, gutsy managerial things like that if there is no ability to communicate that effectively to the market so shareholders can be rewarded for their good decisions.
So, I have few issues with how they have managed the company internally but their management of external affairs, primarily convincing the market they have an amazing , intriguing future in two major drug markets, they have left so much on the table during one of the biggest bull markets of all time.
They could not even arrange for a large short position on the stock which, had they done so, TH's stock price would be soaring right now (that is a joke, just in case people are not aware of what is going on in the states the last few days with heavily shorted stocks soaring).
jeffm34 wrote: The only thing people were wrong about was managements ability to run the company successfully. If the same group is trying to take this company forward then they will likely continue making the same mistakes.